Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on March 16, 2005
J Am Soc Nephrol 16: 1512-1521, 2005
© 2005 American Society of Nephrology
doi: 10.1681/ASN.2004090813

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2004090813v1
16/5/1512    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Keith, D. S.
Right arrow Articles by Norman, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Keith, D. S.
Right arrow Articles by Norman, D. J.

Clinical Transplantation

Factors Associated with Improvement in Deceased Donor Renal Allograft Function in the 1990s

Douglas S. Keith*, Angelo deMattos§, Muralikrishna Golconda||, Jonathan Prather||, Marcelo Cantarovich{dagger}, Steven Paraskevas{ddagger}, Jean Tchervenkov{ddagger} and Douglas J. Norman||

Departments of * Nephrology, {dagger} Transplantation, and {ddagger} Surgery, McGill University Health Center, Royal Victoria Hospital, Montreal, Quebec, Canada; § Department of Nephrology, University of Alabama at Birmingham, Birmingham, Alabama; and || Department of Nephrology, Oregon Health and Science University, Portland, Oregon

Address correspondence to: Dr. Douglas S. Keith, McGill University Health Center, Royal Victoria Hospital, Department of Nephrology, 687 Avenue Des Pins Montreal, PQ, Canada H3A 1A1. Phone: 514-843-1586; Fax: 514-843-2815; E-mail: Douglas.Keith{at}muhc.mcgill.ca

Received for publication September 30, 2004. Accepted for publication January 31, 2005.

The decade of the 1990s saw an improvement in cadaveric renal graft function and dramatic reduction in the acute rejection (AR) rate. The purpose of this study was to determine whether the reduction in rejection rate was the primary cause of the improvement in graft function seen and whether this improved long-term graft survival. All adult patients who received a cadaver renal transplant between 1991 and 2000 and had graft survival of at least 6 mo and complete data for creatinine at 6 mo, HLA mismatch, delayed graft function, and acute rejection (AR) were identified in the United Network for Organ Sharing database. A total of 40,164 cases that met the inclusion criteria were identified. The mean Modification of Diet in Renal Disease GFR at 6 mo improved from 49.94 ml/min per 1.73 m2 in 1991 to 54.59 ml/min per 1.73 m2 in 2000 (P < 0.001). The improvement in GFR was not gradual but occurred over a 4-yr period between 1994 and 1997, coinciding with the introduction of new immunosuppressive agents mycophenolate mofetil and tacrolimus into maintenance immunosuppression regimens. The improvement was seen in all subgroups of patients, even patients without clinical AR or delayed graft function. The magnitude of improvement in patients without clinical AR was similar to that seen in patients with AR. The drop in clinical AR rate accounted for a minority of the improvement in graft function in the 1990s. Other factors, such as reduced drug toxicity and improved control of subclinical rejection, seem to account for the majority of the improvement. This improvement in graft function at 6 mo did not translate into improved long-term graft survival, however.




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
A. Kukla, M. Adulla, J. Pascual, M. Samaniego, L. Nanovic, B. N. Becker, and A. Djamali
CKD stage-to-stage progression in native and transplant kidney disease
Nephrol. Dial. Transplant., February 1, 2008; 23(2): 693 - 700.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. Djamali, E. A. Sadowski, R. J. Muehrer, S. Reese, C. Smavatkul, A. Vidyasagar, S. B. Fain, R. C. Lipscomb, D. H. Hullett, M. Samaniego-Picota, et al.
BOLD-MRI assessment of intrarenal oxygenation and oxidative stress in patients with chronic kidney allograft dysfunction
Am J Physiol Renal Physiol, February 1, 2007; 292(2): F513 - F522.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
A. Djamali, M. Samaniego, B. Muth, R. Muehrer, R. M. Hofmann, J. Pirsch, A. Howard, G. Mourad, and B. N. Becker
Medical Care of Kidney Transplant Recipients after the First Posttransplant Year
Clin. J. Am. Soc. Nephrol., July 1, 2006; 1(4): 623 - 640.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP